DIPEPTIDYL PEPTIDASE-4 INHIBITORS FOR TOPICAL EYE TREATMENT OF RETINAL NEURODEGENERATIVE DISEASES
The invention relates to dipeptidyl peptidase-4 inhibitors, including saxagliptin and sitagliptin, for use in the topical eye treatment and/or prevention of retinal neurodegenerative diseases, in particulardiabetic retinopathyand its associated microvascular impairment. The invention also encompasse...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
04.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to dipeptidyl peptidase-4 inhibitors, including saxagliptin and sitagliptin, for use in the topical eye treatment and/or prevention of retinal neurodegenerative diseases, in particulardiabetic retinopathyand its associated microvascular impairment. The invention also encompasses pharmaceutical topicaleyecompositions for use in the topicaltreatment and/or prevention of these diseases.
本发明涉及用于局部眼部治疗和/或预防视网膜神经退行性疾病、特别是糖尿病视网膜病变及其相关的微血管损伤的二肽基肽酶-4抑制剂,包括沙格列汀和西格列汀。本发明还包括用于局部治疗和/或预防这些疾病的药物局部眼用组合物。 |
---|---|
Bibliography: | Application Number: CN201780030017 |